[Depth] Mobile Medical in the Cold Winter: Realizing the Ability to Change Capital "Ammunition"

tell a story? Looking at income? Spell mode? The financing of mobile medical projects is becoming more and more difficult. For many investors, it is normal to see one hundred projects to vote for one target.

As in 2015, there is a good-looking project plan, and the era when a team that can tell stories can be fully funded has passed.

However, in this capital winter, there is still a large amount of investment funds in the field. For example, a good doctor was reported by the media not long ago to plan a round of financing. If the progress is smooth, the valuation will reach 3 billion to 40. Billions of dollars, and a number of investment institutions have participated in the inquiry. This means that if it is successfully financed, Ping An will fully surpass the $394 million financing it received in September 2015 and the registered network with a valuation above $1.5 billion. The valuation of mobile medical projects will hit a new high.

“The question that investors often care about is what does your project take to realize it?” Zeng Xiaojun, chief strategy officer and managing partner of Gao Tejia Investment Group, said in an interview with the author, “Consumers hope to find a good doctor and simplify the process of seeing through you. The hospital hopes to make management more efficient through you; pharmaceutical and medical device manufacturers hope that you can conduct more precise targeted marketing. Mobile medical projects must generate value in the involved links before they are worth investing ."

In Zeng Xiaojun's view, among the many links involved in mobile medical care, health management, self-diagnosis, self-medication, clinical consultation, waiting for treatment, and out-of-hospital rehabilitation have been able to migrate from offline to online; while diagnosis, treatment, and in-hospital rehabilitation are higher. Technical barriers are also mainly offline.

"For the hospital, the core of the current situation is still to solve the treatment efficiency." Zeng Xiaojun expressed his opinion, "Whoever solves the problem is more efficient, and whoever has the possibility of realizing it."

In fact, the author found in the interview that the liquidity and profit model have become the key to whether mobile medical projects can obtain ammunition in this capital winter.

“When we were in Series A financing, investors were most concerned about the general direction of the project. At that time, financing was easy, and now (B round) investors will pay more attention to some pragmatic aspects, all of which are related to cash flow. Realizing relevant issues." Sun Guangfeng, founder of the Oral Medical O2O platform, said in an interview with the author that their B-round financing is nearing completion.

Plant Extracts(supplement)

Natural weight loss

Xi'an complex bio-tech CO.,LTD. , https://www.complexpowder.com